These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32778108)

  • 1. Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study.
    Tibi-Lévy Y; Serebryakova D; Jauffret-Roustide M;
    Harm Reduct J; 2020 Aug; 17(1):55. PubMed ID: 32778108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
    Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M;
    BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported injection practices among people who use drugs in French prisons: Public health implications (ANRS-Coquelicot survey 2011-2013).
    Michel L; Trouiller P; Chollet A; Molinier M; Duchesne L; Jauffret-Roustide M;
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S268-S276. PubMed ID: 29105203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
    Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
    Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.
    Robertson AM; Garfein RS; Wagner KD; Mehta SR; Magis-Rodriguez C; Cuevas-Mota J; Moreno-Zuniga PG; Strathdee SA;
    Harm Reduct J; 2014 Feb; 11():4. PubMed ID: 24520885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
    Muncan B; Walters SM; Ezell J; Ompad DC
    Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis.
    Ahmed T; Long TN; Huong PT; Stewart DE
    BMC Public Health; 2015 Jan; 15():32. PubMed ID: 25631330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study.
    Jauffret-Roustide M; Emmanuelli J; Quaglia M; Barin F; Arduin P; Laporte A; Desenclos JC
    Subst Use Misuse; 2006; 41(10-12):1603-21. PubMed ID: 17002994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study.
    Dunleavy K; Hope V; Roy K; Taylor A
    Int J Drug Policy; 2019 Mar; 65():65-72. PubMed ID: 30665085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration to the US among rural Puerto Ricans who inject drugs: influential factors, sources of support, and challenges for harm reduction interventions.
    Abadie R; Habecker P; Gelpi-Acosta C; Dombrowski K
    BMC Public Health; 2019 Dec; 19(1):1710. PubMed ID: 31856774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far will they go? Assessing the travel distance of current and former drug users to access harm reduction services.
    Allen S; Ruiz M; O'Rourke A
    Harm Reduct J; 2015 Mar; 12():3. PubMed ID: 25889589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
    Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P
    PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study.
    Biello K; Salhaney P; Valente PK; Childs E; Olson J; Earlywine JJ; Marshall BD; R Bazzi A
    Drug Alcohol Depend; 2020 Sep; 214():108167. PubMed ID: 32679521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of Columbia.
    Allen ST; Ruiz MS; Jones J
    J Urban Health; 2016 Feb; 93(1):131-40. PubMed ID: 26786782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.